Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The effect of radiation therapy on normal tissue function.

T J FitzGerald1, Jesse Aronowitz, M Giulia Cicchetti

  • 1Department of Radiation Oncology and the Cancer Center, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01625, USA. fitzgert@ummhc.org

Hematology/Oncology Clinics of North America
|April 4, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: Importance of quality assurance in radiation oncology clinical trials.

Frontiers in oncology·2026
Same author

A UCP1-IRES-Cre Knock-In Mouse Enables Specific Brown Adipocyte Targeting Without CNS Off-Target Expression.

Research square·2026
Same author

Chromosomal Microarray Analysis in Critically Ill Neonates and Children: Diagnostic Yield and Clinical Utility.

Life (Basel, Switzerland)·2026
Same author

Breast Cancer Reirradiation Practice Patterns: An International Survey From the Reirradiation Collaborative Group (ReCOG).

Practical radiation oncology·2026
Same author

Constraints, Cumulative Doses and Toxicity Outcomes in Glioma Reirradiation: A Systematic Review and Radiobiological Comparison From the Reirradiation Collaborative Group (ReCog).

International journal of radiation oncology, biology, physics·2026
Same author

Reirradiation Collaborative Group (ReCOG) consensus on standards for dose evaluation and reporting in patients with multiple courses of radiation therapy: an AAPM/ACRO/ASTRO/CARO/COMP/CADRA/CPQR/ESTRO/NRG-endorsed consensus statement.

The Lancet. Oncology·2026

As cancer treatments improve, normal tissue injury becomes a key concern. Future radiation therapy protocols will focus on limiting this toxicity while maintaining tumor control, using advanced analysis and imaging.

Area of Science:

  • Radiation Oncology
  • Medical Physics
  • Clinical Oncology

Background:

  • Increasingly effective cancer treatments lead to better survival rates, making normal tissue toxicity a more prominent issue.
  • Toxicity endpoints are becoming crucial for modifying future treatment protocols in oncology.
  • Hodgkin's disease protocols currently prioritize response-based strategies to limit therapy intensity.

Purpose of the Study:

  • To maintain current levels of tumor control in Hodgkin's disease.
  • To analyze outcomes based on normal tissue endpoints.
  • To integrate toxicity data into treatment strategy modifications.

Main Methods:

  • Utilizing dose-volume histogram (DVH) analysis for evaluating normal tissue endpoint data.
  • Implementing image-guided platforms for advanced radiation therapy delivery.

Related Experiment Videos

  • Adapting current response-based treatment strategies to incorporate toxicity data.

    • Main Results:

    • DVH analysis enhances the ability to assess normal tissue damage.
    • Image-guided platforms are essential for future radiation therapy advancements.
    • The study aims to establish a framework for outcome analysis based on normal tissue toxicity.

    Conclusions:

    • Normal tissue toxicity is an increasingly important endpoint in radiation oncology.
    • Future radiation therapy protocols will likely be guided by toxicity data.
    • Advanced imaging and analysis techniques are vital for improving radiation therapy delivery and patient outcomes.